Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Street Poller Media and The Boom of the Street Interview Ad Industry 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Toyota Global Sales Fall as China Demand Slumps 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Add as a preferred source on Google
LISLE, Ill., April 03, 2018 -- CTS Corporation (NYSE:CTS) today announced that Alfonso G. Zulueta, President of Lilly International and Senior Vice President of Eli Lilly and Company, has been appointed to its board of directors, effective April 2, 2018.
Mr. Zulueta is a member of Lilly’s Executive Committee and is responsible for commercial operations for the company's human pharmaceutical products in all markets outside of the U.S., Canada, China, and Japan. Over his 30-year career with Lilly, Mr. Zulueta held key senior positions including president of global oncology and critical care products, president of Asia and president of the Emerging Markets business unit, and has contributed to both product and operational growth of the company internationally.
Mr. Zulueta holds a bachelor’s degree in economics from De La Salle University in the Philippines and an MBA from the University of Virginia. He currently serves as a director on the board of the European Federation of Pharmaceutical Industries and Associations.
CTS’ Chairman and CEO, Kieran O’Sullivan, stated “CTS is delighted that Alfonso has joined our board. His broad international experience and deep knowledge of pharmaceutical and medical markets will be extremely helpful as we continue to focus on growth.”
About CTS
CTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia. CTS provides solutions to OEMs in the aerospace, communications, defense, industrial, information technology, medical, and transportation markets.
For more information, visit www.ctscorp.com.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA
Telephone: +1 (630) 577-8800
E-mail: [email protected]
